XML 49 R35.htm IDEA: XBRL DOCUMENT v3.10.0.1
Employee Benefits and Stock Compensation (Tables)
12 Months Ended
Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Share-Based Compensation
The impact of share-based compensation on the Company’s financial results is presented below:
 
 
 
For the Year Ended December 31,
(In thousands)
 
2018
 
2017
 
2016
Share-based compensation expense
 
$
7,823

 
$
5,267

 
4,154

Income tax benefit
 
(1,911
)
 
(1,966
)
 
(1,602
)
Schedule of Unrecognized Compensation Cost, Nonvested Awards
The total unrecognized compensation cost and the weighted-average period over which unrecognized compensation cost is expected to be recognized related to non-vested share-based compensation arrangements at December 31, 2018 is presented below:
 
(In thousands)
 
Unrecognized
Compensation
Cost
 
Weighted-Average Period Remaining (Years)
Restricted stock awards
 
$
4,637

 
1.5
Restricted stock units
 
4,319

 
1.7
Stock options
 
1,653

 
1.8
Total
 
$
10,609

 
1.7
Schedule of Nonvested Share Activity
A summary of the status of the Company’s non-vested RSUs as of December 31, 2018, and changes during the year then ended, is presented below:
 
 
 
Restricted
Award
Shares
 
Weighted-Average Grant-Date Fair Value
Non-vested at January 1, 2018
 
375,967

 
$
16.96

Granted
 
173,193

 
24.02

Forfeited/Canceled
 
(247
)
 
10.50

Vested
 
(82,077
)
 
13.34

Non-vested at December 31, 2018
 
466,836

 
20.22

A summary of the status of the Company’s non-vested RSAs as of December 31, 2018, and changes during the year then ended, is presented below:
 
 
 
Restricted
Award
Shares
 
Weighted-Average Grant-Date Fair Value
Non-vested at January 1, 2018
 
187,511

 
$
19.18

Granted
 
242,613

 
26.48

Forfeited/Canceled
 
(15,514
)
 
25.47

Vested
 
(119,480
)
 
21.05

Non-vested at December 31, 2018
 
295,130

 
24.09

Schedule of Restricted Stock and Restricted Stock Units Activity
Information regarding restricted stock units during each of the following years:

     
 
 
For the Year Ended December 31,
 
 
2018
 
2017
 
2016
Shares granted
 
173,193

 
164,268

 
136,188

Weighted-average grant date fair value
 
$
24.02

 
$
23.94

 
$
13.53

Fair value of awards vested(1)
 
$
1,095

 
$
937

 
$
846

(1)Based on grant date fair value
Information regarding restricted stock awards during each of the following years:
 
 
 
Year Ended December 31,
 
 
2018
 
2017
 
2016
Shares granted
 
242,613

 
114,331

 
164,599

Weighted-average grant date fair value
 
$
26.48

 
$
24.08

 
$
16.03

Fair value of awards vested(1)
 
$
2,515

 
$
1,407

 
$
1,981

(1)Based on grant date fair value
Schedule of Stock Option Valuation Assumptions
The Company estimated the fair value of each option grant on the date of grant using the Black-Scholes options-pricing model with the following weighted-average assumptions:
 
    
 
 
For the Year Ended December 31,
 
 
2018
 
2017
 
2016
Risk-free interest rates
 
2.56
%
 
1.85
%
 
1.63
%
Expected dividend yield
 
0
%
 
0
%
 
0
%
Expected volatility
 
26.6
%
 
25.4
%
 
21.9
%
Expected lives (years)
 
5.0

 
5.0

 
5.0

Schedule of Stock Options Roll Forward
A summary of the Company’s stock options as of December 31, 2018, and changes during the year then ended, are presented below:
 
 
 
Options
 
Weighted-Average Exercise Price
 
Weighted-Average Remaining Contractual Term (Years)
 
Aggregate
Intrinsic
Value
(000s)
Outstanding at January 1, 2018
 
951,349

 
$
17.29

 
 
 
 
Granted
 
219,118

 
30.98

 
 
 
 
Exercised
 
(175,541
)
 
11.45

 
 
 
 
Forfeited
 
(61,431
)
 
11.17

 
 
 
 
Outstanding at December 31, 2018
 
933,495

 
22.00

 
7.09
 
$
5,569

Exercisable at December 31, 2018
 
447,033

 
16.50

 
6.04
 
4,511

Schedule of Stock Option Activity
Information related to stock options during each of the following years:
 
 
 
For the Year Ended December 31,
 
 
2018
 
2017
 
2016
Options granted
 
219,118

 
297,576

 
243,391

Weighted-average grant date fair value
 
$
5.65

 
$
4.66

 
$
3.41

Intrinsic value of stock options exercised
 
3,045

 
1,143

 
80

Schedule of Options Outstanding and Remaining Contractual Life of Stock Options
The following table summarizes information related to stock options as of December 31, 2018:
 
Range of Exercise Prices
 
Options
Outstanding
 
Remaining
Contractual
Life (Years)
 
Options
Exercisable
 
Weighted
Average
Exercise
Price
$10.54 to $14.82
 
391,113

 
5.2
 
311,759

 
$
12.23

$15.99 to $28.69
 
333,281

 
8.0
 
135,274

 
26.35

$31.15 to $31.15
 
209,101

 
9.3
 

 

Total
 
933,495

 
7.1
 
447,033

 
$
16.50

Schedule of Employee Stock Purchase Plan Activity
Employee contributions to the ESPP are made through payroll deductions.
 
 
 
2018
 
2017
 
2016
ESPP shares purchased
 
15,225

 
12,434

 
10,483

Weighted-average employee purchase price
 
$
26.85

 
$
22.67

 
$
16.02